Hansen, D., Peres, L., Dima, D., Zanwar, S., Puglianini, O. A. C., Richards, A., Gaballa, M., Pasvolsky, O., Afrough, A., Reid, B., Grajales-Cruz, A., Xie, Z., Goel, U., Sannareddy, A., Dillard, C., Ferreri, C., Atrash, S., Varga, C., Portuguese, A., Hosoya, H., Mikkilineni, L., Kalariya, N., Mikulski, D., Wagner, C., Cahoon, C., Cheng, P., Gordillo, C., Zolotov, E., Bhurtel, E., Kort, J., Cassano, R. C., Midha, S., Davis, J., Gonzalez, R., Herr, M., Hassan, H., Purvey, S., Geer, M., Green, K., Perna, F., Liu, H., Nishihori, T., Khouri, J., Raza, S., Anwer, F., Bal, S., Nadeem, O., Freeman, C. L., Banerjee, R., Shune, L., Reshef, R., Shain, K., Alsina, M., Baz, R., Sborov, D., Voorhees, P., Anderson, L., Costa, L., Biran, N., Kumar, S., Locke, F., Lin, Y., Sidana, S., Patel, K. (2025). Predictors of early relapse following ciltacabtagene autoleucel: Informing risk-adapted therapy in relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-93